tailieunhanh - Relapsing pneumonitis due to two distinct inhibitors of the MAPK/ERK pathway: Report of a case

BRAF and MEK are component of the MAPK/ERK pathway and inhibitors of these proteins have significantly improved the outcome of metastatic melanoma. We report for the first time two sequential episodes of pneumonitis presumably induced by trametinib (a MEK inhibitor) and vemurafenib (a BRAF inhibitor) in a 50 year-old man. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN